Your body already has a built-in weight loss system that works like Wegovy, Ozempic and Mounjaro – food and your gut microbiome

Here is the rewritten content:

Your Body Already Has a Built-in Weight Loss System That Works Like Wegovy, Ozempic, and Mounjaro – Food and Your Gut Microbiome

Wegovy, Ozempic, and Mounjaro are weight loss and diabetes drugs that have made quite a splash in health news. They target regulatory pathways involved in both obesity and diabetes and are widely considered breakthroughs for weight loss and blood sugar control.

- Advertisement -

But do these drugs point toward a root cause of metabolic disease? What inspired their development in the first place?

It turns out your body produces natural versions of these drugs – also known as incretin hormones – in your gut. It may not be surprising that nutrients in food help regulate these hormones. But it may intrigue you to know that the trillions of microbes in your gut are key for orchestrating this process.

A Broken Gut

Specialized bacteria in your lower gut take the components of food you can’t digest like fiber and polyphenols – the elements of plants that are removed in many processed foods – and transforms them into molecules that stimulate hormones to control your appetite and metabolism. These include GLP-1, a natural version of Wegovy and Ozempic.

GLP-1 and other hormones like PYY help regulate blood sugar through the pancreas. They also tell your brain that you’ve had enough to eat and your stomach and intestines to slow the movement of food along the digestive tract to allow for digestion. This system even has a name: the colonic brake.

A Short Track to Metabolic Health

Wegovy and Ozempic reinvigorate the colonic brake downstream of food and microbes with molecules similar to GLP-1. Researchers have demonstrated their effectiveness at weight loss and blood sugar control.

Mounjaro has gone a step further and combined GLP-1 with a second hormone analogue derived from the upper gut called GIP, and studies are showing this combination therapy to be even more effective at promoting weight loss than GLP-1-only therapies like Wegovy and Ozempic.

These drugs complement other measures like gastric bypass surgery that are used in the most extreme cases of metabolic disease. These surgeries may in part work much like Wegovy and Ozempic by bypassing digestion in segments of the gastrointestinal tract and bathing your gut microbes in less digested food. This awakens the microbes to stimulate your gut cells to produce GLP-1 and PYY, effectively regulating appetite and metabolism.

A Near-Magic Bullet – for the Right Folks

Despite the success and prospect of these drugs to help populations that may benefit most from them, current prescribing practices have raised some questions. Should people who are only a little overweight use these drugs? What are the risks of prescribing these drugs to children and adolescents for lifelong weight management?

While incretin-based therapies seem close to magic bullets, they are not without gastrointestinal side effects like nausea, vomiting, diarrhea, and constipation. These symptoms are related to how the drugs work to slow the gastrointestinal tract. Other more severe, but rare, side effects include pancreatitis and irreversible gastroparesis, or inflammation of the pancreas and stomach paralysis.

All Roads Lead to Lifestyle

Despite our greatest aspirations for quick fixes, it’s very possible that a healthy lifestyle remains the most important way to manage metabolic disease and overall health. This includes regular exercise, stress management, sleep, getting outdoors, and a balanced diet.

For the majority of the population who don’t yet have obesity or diabetes, restarting the gut’s built-in appetite and metabolism control by reintroducing whole foods and awaking the gut microbiome may be the best approach to promote healthy metabolism.

Adding minimally processed foods back to your diet, and specifically those replete in fiber and polyphenols like flavonoids and carotenoids, can play an important and complementary role to help address the epidemic of obesity and metabolic disease at one of its deepest roots.

Conclusion

In conclusion, the natural system of appetite and metabolism control in the gut microbiome is a crucial part of our body’s weight loss and blood sugar regulation. The success of incretin-based medications like Wegovy, Ozempic, and Mounjaro highlights the importance of understanding and harnessing this natural system.

FAQs

Q: What are incretin hormones?
A: Incretin hormones are natural hormones produced in the gut that help regulate appetite and metabolism.

Q: How do incretin-based medications work?
A: Incretin-based medications work by mimicking the action of incretin hormones to slow the gastrointestinal tract and regulate appetite and metabolism.

Q: What are the benefits of incretin-based medications?
A: Incretin-based medications have been shown to be effective in promoting weight loss and improving blood sugar control.

Q: What are the risks of incretin-based medications?
A: Incretin-based medications can have gastrointestinal side effects like nausea, vomiting, diarrhea, and constipation, and rare but severe side effects like pancreatitis and irreversible gastroparesis.

Q: Can a healthy lifestyle help manage metabolic disease?
A: Yes, a healthy lifestyle that includes regular exercise, stress management, sleep, getting outdoors, and a balanced diet can help manage metabolic disease.